BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 7, 2012
View Archived Issues
New phosphodiesterase 10A inhibitors discovered
Read More
Phase II trial of CTP-499 advances
Read More
FluoroPharma Medical plans phase II study of cardiac imaging agent
Read More
Icatibant acetate may improve acquired angioedema
Read More
New chemokine CCR8 receptor antagonists identified at AstraZeneca
Read More
Novel kinase inhibitors developed in Spain
Read More
Roche patents new candidate hepatitis C therapies
Read More
New renin inhibitors designed in China
Read More
Collaborating companies in Japan synthetize novel CKI inhibitors
Read More
Advinus Therapeutics announces novel glucokinase activators
Read More
Seglin OGA inhibitors show promise in vivo
Read More
Madrigal launches new phase I trial of cholesterol-lowering agent
Read More
EyeGate Pharma begins phase I trial in anterior scleritis
Read More
FDA supports initiation of pivotal DSC-127 trials
Read More
EMA grants orphan drug status to Cytokinetics drug in ALS
Read More
New Taisho drug has promising pharmacological profile
Read More
Novel SYK inhibitor shows potential as asthma therapeutic
Read More
Miraculins provides details on FDA's clearance of cholesterol test
Read More
Eisai receives complete response letter on Dacogen
Read More
Stem cell product set to be assessed in patients with artery disease
Read More
FDA approves Surfaxin
Read More
AcelRx advances patient-controlled analgesia system to phase III
Read More
More encouraging results reported on levomilnacipran in MDD
Read More
Michael J. Fox Foundation awards funding to QR Pharma
Read More
Abbott to develop companion diagnostic for Merck & Co. anticancer candidate
Read More
